NEW YORK (GenomeWeb) – After several extensions, Abbott completed its tender offer to purchase all outstanding shares of Alere's Series B convertible perpetual preferred stock at $402 per share.

The offer was made in connection with Abbott's acquisition of Alere, which was completed on Tuesday. The offer expired at 11:59 p.m. the same day.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.